21011 ⎘
Medicinal preparations containing peptides; Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans; Blood coagulation or fibrinolysis factors Thrombomodulin
THROMBOMODULIN PROTEIN AND MIRNA FOR PREVENTING OR TREATING OSTEOATHRITIS
#2BIOMARKERS TO DETECT RISK OF SINUSOIDAL OBSTRUCTION SYNDROME
#3COMPOSITIONS AND METHODS FOR TREATING HAIR LOSS OR FACILITATING HAIR GROWTH
#4Therapeutic Targeting of Lipid Nanoparticles
#5MEDICAMENT FOR THERAPEUTIC TREATMENT AND/OR IMPROVEMENT OF SEPSIS ACCOMPANIED BY COAGULOPATHY
#6HIGH CONCENTRATED PROTEIN COMPOSITIONS FOR PREVENTING TISSUE ADHESION
#7A HEMOSTATIC AGENT AND USES THEREOF
#8THROMBOMODULIN FUNCTIONAL DOMAINS FOR USE IN PROMOTING OSTEOBLAST FUNCTIONS AND BONE HEALING
#9MICROVASCULAR BLOOD FLOW DECREASING AGENT AND USE THEREOF
#10Recombinant thrombomodulin domain 1 for use in treating eye diseases associated with pathological ocular angiogenesis
#11Fine nano-sized medicinal agent and use thereof
#12COMPOSITIONS AND METHODS FOR TREATING PSEUDOANEURYSM
#13Low concentrated protein compositions for preventing tissue adhesion
#14High concentrated protein compositions for preventing tissue adhesion
#15Medicament for mitigating conditions and/or suppressing onset of peripheral neuropathy induced by anti-malignant tumor agent
#16Therapeutic Targeting of Lipid Nanoparticles
#17Microvascular blood flow decreasing agent and use thereof
#18Thrombin-thrombomodulin fusion proteins as a powerful anticoagulant
#19Anti-histone therapy in acute kidney injury
#20Three dimensional healing kit
#21TMD1 protein for treating bone loss diseases
#22Methods for treatment of CD14-mediated disorders and responses
#23Medicament for therapeutic treatment and/or improvement of sepsis
#24Anti-histone therapy for vascular necrosis in severe glomerulonephritis
#25Medicament for therapeutic treatment and/or improvement of sepsis
#26Agent for prophylactic and/or therapeutic treatment of peripheral neuropathic pain caused by anticancer agent
#27Thrombomodulin variants and use thereof
#28Compositions and Methods for the Generation of Activated Protein C and Methods of Use Thereof
#29Medicament for therapeutic treatment and/or improvement of sepsis
#30MEDICAMENT FOR THERAPEUTIC TREATMENT AND/OR IMPROVEMENT OF SEPSIS
#31Medicament for therapeutic treatment and/or improvement of sepsis
#32Pharmacological treatment of aortic aneurysm development
#33TREATMENT OF COAGULOPATHY WITH HYPERFIBRINOLYSIS
#34METHODS FOR BINDING LEWIS Y ANTIGEN
#35COMPOSITIONS CONTAINING THROMBOMODULIN DOMAINS AND USES THEREOF
#36METHOD FOR PROPHYLACTIC AND/OR THERAPEUTIC TREATMENT OF PAIN ASSOCIATED WITH HEMATOPOIETIC CELL TRANSPLANTATION
#37COMPOSITIONS AND METHODS OF USE FOR SOLUBLE THROMBOMODULIN VARIANTS
#38PREVENTION AND TREATMENT OF RADIATION INJURY
#39Method for identifying a non-anticoagulant sulfated polysaccharide which enhances blood coagulation dependence on FXI
#40Methods and compositions for treating ischemia
#41METHODS AND COMPOSITIONS FOR INTRA-ARTICULAR COAGULATION PROTEINS
#42METHODS FOR BINDING LEWIS Y ANTIGEN
#43THROMBOMODULIN ANALOGS FOR USE IN RECOVERY OF SPINAL CORD INJURY
#44Ex vivo and in vivo expression of the thrombomodulin gene for the treatment of cardiovascular and peripheral vascular diseases
#45Methods and compositions for promoting angiogenesis
#46Ex vivo and in vivo expression of the thrombomodulin gene for the treatment of cardiovascular and peripheral vascular diseases
#47Ex vivo and in vivo expression of the thrombomodulin gene for the treatment of cardiovascular and peripheral vascular diseases
#48Ex vivo and in vivo expression of the thrombomodulin gene for the treatment of cardiovascular and peripheral vascular diseases
#49Ex vivo and in vivo expression of the thrombomodulin gene for the treatment of cardiovascular and peripheral vascular diseases
#50Method for treating wounds using an EGF-like domain of thrombomodulin
#51Novel angiogenic composition and use thereof
#52High-concentration preparation of soluble thrombomodulin